VXRT
What one share of Vaxart holds
Biological Products, (No Diagnostic Substances)
Vaxart Biosciences, Inc. was originally incorporated in California under the name West Coast Biologicals, Inc. in March 2004 and changed its name to Vaxart, Inc. (“Private Vaxart”) in July 2007, when it reincorporated in the state of Delaware.
Vaxart’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.03 |
|---|---|
| Profit | $0.16 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.14 |
| Cash and investments | $0.21 |
| Book value | $0.34 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $42.95 | −$91.65 | $0.86 | −$74.71 | — | −$279.60 |
| 2018 | $0.66 | −$2.90 | $0.11 | −$2.42 | — | $1.57 |
| 2019 | $0.46 | −$0.86 | $0.04 | −$0.65 | — | — |
| 2020 | $0.05 | −$0.36 | $0.01 | −$0.28 | — | $1.12 |
| 2021 | $0.01 | −$0.58 | $0.04 | −$0.54 | — | $1.49 |
| 2022 | $0.00 | −$0.84 | $0.08 | −$0.82 | — | $0.82 |
| 2023 | $0.05 | −$0.57 | $0.01 | −$0.50 | — | $0.38 |
| 2024 | $0.14 | −$0.33 | $0.00 | −$0.22 | — | $0.26 |
| 2025 | $1.03 | $0.07 | $0.00 | $0.03 | — | $0.37 |